- Home
- UL vs MDT Comparison
UL vs MDT Comparison
Compare UL & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UL
- MDT
- Stock Information
- Founded
- UL 1930
- MDT 1949
- Country
- UL United Kingdom
- MDT Ireland
- Employees
- UL N/A
- MDT N/A
- Industry
- UL Package Goods/Cosmetics
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- UL Consumer Discretionary
- MDT Health Care
- Exchange
- UL Nasdaq
- MDT Nasdaq
- Market Cap
- UL 143.0B
- MDT 116.9B
- IPO Year
- UL N/A
- MDT N/A
- Fundamental
- Price
- UL $57.91
- MDT $87.62
- Analyst Decision
- UL Buy
- MDT Hold
- Analyst Count
- UL 4
- MDT 16
- Target Price
- UL $60.00
- MDT $94.07
- AVG Volume (30 Days)
- UL 2.1M
- MDT 5.9M
- Earning Date
- UL 07-25-2024
- MDT 11-19-2024
- Dividend Yield
- UL 3.28%
- MDT 3.19%
- EPS Growth
- UL N/A
- MDT 9.56
- EPS
- UL 2.82
- MDT 2.97
- Revenue
- UL $64,601,950,064.00
- MDT $32,577,000,000.00
- Revenue This Year
- UL $2.95
- MDT $4.92
- Revenue Next Year
- UL $3.20
- MDT $4.77
- P/E Ratio
- UL $19.97
- MDT $29.50
- Revenue Growth
- UL N/A
- MDT 3.23
- 52 Week Low
- UL $46.46
- MDT $74.66
- 52 Week High
- UL $65.87
- MDT $92.68
- Technical
- Relative Strength Index (RSI)
- UL 32.02
- MDT 43.49
- Support Level
- UL $56.87
- MDT $85.01
- Resistance Level
- UL $57.65
- MDT $92.03
- Average True Range (ATR)
- UL 0.52
- MDT 1.59
- MACD
- UL -0.25
- MDT -0.31
- Stochastic Oscillator
- UL 20.68
- MDT 37.18
About UL Unilever PLC
Unilever is a diversified personal-care (52% of 2022 sales by value), homecare (14%), and packaged food (34%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Axe and Dove skin products, and the TRESemmé haircare brand. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, Garancia, and The Vegetarian Butcher.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.